Mani Mohindru, CFO & Chief Strategy Officer at Cara Therapeutics, Inc. (CARA), sold 32,084 shares at $20.19 ($648K) on 2018-10-17, disclosed to the SEC on 2018-10-19.
Open-market sale of $648k CARA by CFO & Chief Strategy Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $20.19 | 16,042 | $324K | 50.0% |
| 2 | $20.19 | 16,042 | $324K | 50.0% |
| Total | $20.19 avg | 32,084 | $648K | 100% |
| Filing → |
| CARA | SELL | 2019-12-04 | $162K | — | Filing → |
| CARA | SELL | 2019-07-17 | $936K | — | Filing → |
| CARA | SELL | 2019-05-30 | $107K | — | Filing → |